Crossmark

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC

Crossref DOI link: https://doi.org/10.1186/s12885-018-4688-8

Published Online: 2018-07-31

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gundlach, Jan-Paul

Hauser, Charlotte

Schlegel, Franka Maria

Böger, Christine

Röder, Christian

Röcken, Christoph

Becker, Thomas

Egberts, Jan-Hendrik

Kalthoff, Holger

Trauzold, Anna https://orcid.org/0000-0003-4697-556X
Funding

Funding for this research was provided by:

Christian-Albrechts-Universität zu Kiel

Erich und Gertrud Roggenbuck-Stiftung
License Information

Text and Data Mining valid from 2018-07-31
More Information

Article History

Received: 10 January 2018

Accepted: 22 July 2018

First Online: 31 July 2018

Ethics approval and consent to participate

: All patients have agreed to participate in the study and have signed informed consent before collecting material. This study was approved by the local institutional review board of the Medical Faculty of the Christian-Albrechts-University of Kiel (A-110/99).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.